Upcoming Half Year Results Presentation by IBA
Louvain-la-Neuve, Belgium - IBA (Ion Beam Applications S.A.) is gearing up to present its consolidated results for the half year 2025. The company, renowned for its leadership in particle accelerator technology, will unveil this significant information on a designated date set for Thursday, 28 August 2025.
The results will be officially published on the morning of the same day, continuing IBA’s commitment to transparency and effective communication with its stakeholders.
Conference Call Details
In conjunction with the results announcement, IBA's management will conduct a conference call and a webcast in English, offering detailed insights into the firm's performance during the first half of 2025. Following the presentation, attendees will have the opportunity to engage directly with the team during a Q&A session, allowing for a deeper understanding of the company's strategic direction and accomplishments.
The conference is scheduled for Thursday, 28 August 2025, at 3pm CEST / 2pm BST / 9am EDT / 6am PDT and will be hosted via Teams. Interested participants should register ahead of time to secure their spot in the webinar. It's recommended to complete registration at least 10 minutes before the start to ensure a smooth experience.
Accessing the Presentation
Participants can expect to access the presentation materials shortly before the conference call. Availability will include resources on IBA's investor relations website, ensuring that all interested parties have the necessary information to follow along during the session.
To participate seamlessly, users should check their connectivity and ensure they are familiar with the Teams platform if they plan to join through it. Detailed instructions can be provided to facilitate access for those who may encounter barriers while trying to connect. IBA values all participants and encourages feedback during the call.
About IBA
IBA stands as a cornerstone in the world of particle accelerator technology, providing cutting-edge solutions in proton therapy, industrial sterilization, radiopharmaceutical production, and dosimetry. With approximately 2,100 employees globally, IBA showcases its international footprint and commitment to innovation in healthcare.
Having achieved B Corporation certification, IBA exemplifies high standards in social responsibility and environmental performance. The company's listing on the pan-European stock exchange EURONEXT (Ticker: IBAB) reflects its stable position in the market, highlighting its potential for growth in the years to come.
For anyone seeking further details or insights, IBA maintains an informative presence online, readily available for stakeholders and public interest.
Frequently Asked Questions
What date will IBA announce its half-year results?
IBA will announce its half-year results on Thursday, 28 August 2025.
How can I participate in the conference call?
To participate, register via the IBA website at least 10 minutes before the call begins.
Where can I find the results presentation?
The presentation will be available on IBA’s investor relations website shortly before the call.
What is IBA's significance in the market?
IBA is the leading supplier of particle accelerator technology, particularly in proton therapy, making significant contributions to healthcare.
How can I contact IBA for more information?
For inquiries, you can contact Thomas Pevenage at investorrelations@iba-group.com.
